Pharmacodynamic/Pharmacokinetic interactions between oral roflumilast and inhaled formoterol

Study identifier:BY217/CP-059

ClinicalTrials.gov identifier:NCT00940329

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Investigation on the cardiovascular and pharmacokinetic interaction between oral roflumilast and inhaled formoterol in healthy subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Roflumilast

Sex

Male

Actual Enrollment

27

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 Apr 2004
Primary Completion Date: 01 Jul 2004
Study Completion Date: 01 Dec 2004

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics/dynamics Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Sept 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria